DV
Dividend Vision

DARE — Dare Bioscience Inc

Dare Bioscience Inc (DARE)

Total return is -99.9% over the past 12.3 years, 520.8 points behind SPY at 420.9%. Its deepest 1-year drawdown was 64.5%.

DARE is an equity fund focused on Dare Bioscience Inc, a single-stock holding in the bioscience sector. The fund does not currently maintain a distribution rate or yield profile, reflecting its focus on a development-stage bioscience company rather than income generation. This fund appeals primarily to investors seeking exposure to emerging biotechnology companies with growth potential rather than those prioritizing dividend income.

DARE key facts

Asset type
Stock
Asset class
Equity
Inception date
04/10/2014
Last close
$0.93
Market cap
$29,359,824
Average volume
8025500.0
Payment date
07/20/2017
Beta
1.025
Payout ratio
0.0
Forward P/E
1.2682
EPS
$-0.91